Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Addition of Rituximab to Leflunomide in patients with active rheumatoid arthritis
2009-015950-39Phase 3Completed
- Sponsor
- Goethe University Frankfurt
- Start
- Dec 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of rituximab in rheumatoid arthritis (RA), sponsored by Goethe University Frankfurt. Primary endpoint: Primary efficacy (Part I). Started Dec 2009; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2009-015950-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015950-39.